Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

9480	Companies
185554	Keywords
117943	Articles
99386	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 05/30/2025 at 22:00, 6 months 5 days ago

Information on the Annual Financial Statements
Biophytis postpones the publication of its 2024 annual financial statements due to technical complications in the audit process. The Company aims to complete the audit by the end of June 2025

Biophytis Audit Postponement 2024 Annual Financial Statements Technical Complications
REGULATED PRESS RELEASE

published on 05/30/2025 at 22:00, 6 months 5 days ago

Information sur les comptes annuels
Biophytis reporte la publication des comptes annuels 2024 en raison de complications techniques dans le processus d'audit. L'assemblée générale des actionnaires est également repoussée

Biophytis Assemblée Générale Comptes Annuels Audit Report
PRESS RELEASE

published on 05/30/2025 at 21:59, 6 months 5 days ago

Information sur les comptes annuels
Biophytis reporte la publication de ses comptes annuels 2024 en raison de complications techniques dans l'audit. L'assemblée générale est également reportée. La société se concentre sur le développement de traitements pour les maladies liées à l'âge

Biophytis Développement Comptes Annuels Report Maladies Liées À L'âge
PRESS RELEASE

published on 05/30/2025 at 21:59, 6 months 5 days ago

Information on the Annual Financial Statements
Biophytis postpones 2024 annual financial statements publication due to technical audit issues, reschedules General Meeting of shareholders following legal procedures

Shareholders Financial Statements Biophytis Meeting Audit
BRIEF

published on 05/15/2025 at 07:05, 6 months 21 days ago

Biophytis présente une avancée dans le traitement de l'obésité à l'ECO 2025

Biophytis Essai Clinique BIO101 Obésité GLP-1
BRIEF

published on 05/15/2025 at 07:05, 6 months 21 days ago

Biophytis Unveils Promising Obesity Treatment at ECO 2025

Biophytis Clinical Trials Obesity Treatment BIO101 ECO 2025
REGULATED PRESS RELEASE

published on 05/15/2025 at 07:00, 6 months 21 days ago

Biophytis Highlights Innovative Approach to Obesity Treatment During Key ECO 2025 Presentation
Biophytis highlights innovative approach to obesity treatment at ECO 2025 presentation, showcasing promising results of BIO101 drug candidate targeting muscle loss in obese patients

Biophytis Obesity Treatment BIO101 ECO 2025 Muscle Loss
REGULATED PRESS RELEASE

published on 05/15/2025 at 07:00, 6 months 21 days ago

Biophytis met en lumière son approche innovante du traitement de l’obésité lors d’une présentation majeure au congrès ECO 2025
Biophytis met en lumière son approche innovante du traitement de l'obésité lors d'une présentation majeure au congrès ECO 2025. Le Dr Serge Camelo présente les dernières données du programme clinique OBA sur BIO101 pour limiter la perte musculaire chez les patients obèses

Biophytis Traitement BIO101 Obésité Congrès ECO 2025
BRIEF

published on 04/25/2025 at 18:05, 7 months 10 days ago

Report de la publication des comptes annuels de Biophytis

Biophytis Biotechnologie Comptes Annuels Refinancement Publication Retardée
BRIEF

published on 04/25/2025 at 18:05, 7 months 10 days ago

Biophytis Delays Release of 2024 Financial Statements

Financial Statements Biophytis Refinancing 2024 Delay

Accesswire

Published on 12/05/2025 at 21:20, 11 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 31 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 1 hour 6 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 1 hour 16 minutes ago

When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 1 hour 41 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 2 hours 33 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 3 hours 5 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 3 hours 16 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 3 hours 39 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 3 hours 45 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 4 hours 13 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 4 hours 13 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 6 hours 20 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 6 hours 20 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 7 hours 33 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE